STOCK TITAN

Avidity Biosciences, Inc. (RNAM) Revenue by Year

RNAM

Avidity Biosciences, Inc. generated $18.8M in revenue in fiscal year 2025. This represents an increase of 72.1% from the prior fiscal year. The table below carries 8 fiscal years, from 2018 to 2025, and the quarters Avidity Biosciences, Inc. has filed alongside them.

FY2025 annual
Revenue $18.8M
YoY +72.1%
5Y CAGR +22.5%
Source SEC Filings (10-K/10-Q) Latest period FY2025, ended Dec 31, 2025 Reported Currency USD

Annual figures, oldest first. Point at a bar to read its period.

RNAM Revenue by Fiscal Year

Figures are as reported in USD. Each change compares the year with the year before it, and each column links to the filing it was taken from.

MetricFY2510-KFY2410-KFY2310-KFY2210-KFY2110-KFY2010-KFY1910-KFY1810-K
Revenue$18.8M+72.1%$10.9M+14.0%$9.6M+3.6%$9.2M-1.1%$9.3M+37.4%$6.8M+192.7%$2.3M+511.9%$379K

RNAM Revenue by Quarter

Figures are as reported in USD. Each change compares the quarter with the same quarter a year earlier.

MetricQ4'2510-KQ3'2510-QQ2'2510-QQ1'2510-QQ4'2410-KQ3'2410-QQ2'2410-QQ1'2410-QQ4'2310-KQ3'2310-QQ2'2310-QQ1'2310-Q
Revenue$860K-71.1%$12.5M+434.0%$3.8M+88.1%$1.6M-55.6%$3.0M+35.6%$2.3M-17.1%$2.0M-11.7%$3.5M+58.7%$2.2M-20.8%$2.8M+13.5%$2.3M+6.3%$2.2M+24.4%

What revenue means

Revenue is everything the company billed its customers over the period, counted before any cost of running the business comes out of it.

More Avidity Biosciences, Inc. financials

Frequently Asked Questions

What was Avidity Biosciences, Inc.'s revenue in fiscal year 2025?

Avidity Biosciences, Inc. generated $18.8M in revenue in fiscal year 2025.

How fast is Avidity Biosciences, Inc.'s revenue growing?

Avidity Biosciences, Inc. (RNAM) revenue rose by 72.1% year over year, from $10.9M to $18.8M in fiscal year 2025.

How has Avidity Biosciences, Inc.'s revenue changed over the years?

Across the 8 fiscal years this page covers, Avidity Biosciences, Inc. (RNAM) revenue went from $379K in fiscal year 2018 to $18.8M in fiscal year 2025.

Avidity Biosciences, Inc. (RNAM) reported $860K in revenue in Q4 2025. This represents a decrease of 71.1% from the same quarter a year earlier.

Revenue is everything the company billed its customers over the period, counted before any cost of running the business comes out of it. This page lists what Avidity Biosciences, Inc. (RNAM) reported on that line in every period on record.